Exploring Space as the Next Frontier for Biopharma R&D: Maureen Haverty, Seraphim Space/Generation Space

May 24, 2023
Share on LinkedIn Share on Twitter Share on Facebook

Exploring Space as the Next Frontier for Biopharma R&D: Maureen Haverty, Seraphim Space/Generation Space

Space exploration and research are rapidly advancing, and life sciences is a key component of this progress. Learn more about the opportunities and developments in space R&D and manufacturing, particularly in the life sciences sector, from Maureen Haverty, VP of Investment at Seraphim Space/Generation Space.

Want more insights on the people, stories and ideas that are changing healthcare into what it should be? Subscribe to our Healthcare Connection newsletter and get transformative ideas delivered to your inbox every month.

Dive Deeper

The FDA Is Raising the Stakes — Here’s How We’re Helping Brands Stay Creative and Compliant
  • Activation
  • Analytics + Insights
  • Artificial Intelligence

The FDA Is Raising the Stakes — Here’s How We’re Helping Brands Stay Creative and Compliant

October 21, 2025
The FDA Is Raising the Stakes — Here’s How We’re Helping Brands Stay Creative and Compliant
  • Activation
  • Analytics + Insights
  • Artificial Intelligence

The FDA Is Raising the Stakes — Here’s How We’re Helping Brands Stay Creative and Compliant

October 21, 2025
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond
  • Activation

Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond

October 15, 2025